Blueprint Investment Partners LLC Astrazeneca PLC Transaction History

Blueprint Investment Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $46,857 - $53,127	742 Added 9.43%	8,613 $597,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $156,179 - $202,937	2,881 Added 57.74%	7,871 $533,000
Q3 2022 Nov 09, 2022	SELL	$53.02 - $135.75 $46,392 - $118,781	-875 Reduced 14.92%	4,990 $274,000
Q2 2022 Aug 09, 2022	SELL	$59.26 - $71.14 $1,362 - $1,636	-23 Reduced 0.39%	5,865 $388,000
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $223,214 - $268,882	4,006 Added 212.86%	5,888 $391,000
Q4 2021 Feb 15, 2022	BUY	$54.02 - $63.83 $11,560 - $13,659	214 Added 12.83%	1,882 $109,000
Q3 2021 Nov 04, 2021	BUY	$55.56 - $60.79 $92,674 - $101,397	1,668 New	1,668 $100,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Blueprint Investment Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Blueprint Investment Partners LLC with notifications on news.